MktsMarkets
AbbVie Inc.
NYSE: ABBVKey statistics
ABBV News
Stories mentioning ABBV from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 15,002,000 | 16,618,000 | 15,776,000 | 15,423,000 | 13,343,000 | 15,102,000 | 14,460,000 | 14,462,000 |
| Cost of Goods Sold | 4,218,000 | 4,552,000 | 5,304,000 | 4,346,000 | 4,002,000 | 4,396,000 | 4,212,000 | 4,202,000 |
| Gross Profit | 10,784,000 | 12,066,000 | 10,472,000 | 11,077,000 | 9,341,000 | 10,706,000 | 10,248,000 | 10,260,000 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 3,578,000 | 3,895,000 | 3,569,000 | 3,253,000 | 3,293,000 | 3,855,000 | 4,205,000 | 3,377,000 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 3,990,000 | 4,544,000 | 1,904,000 | 4,894,000 | 3,733,000 | (1,490,000) | 3,831,000 | 3,998,000 |
| Interest Income | 72,000 | 72,000 | 62,000 | 73,000 | 129,000 | 220,000 | ||
| Interest Expense | 717,000 | 714,000 | 739,000 | 740,000 | 700,000 | 702,000 | 720,000 | 726,000 |
| Other Expense | (2,306,000) | (1,206,000) | (503,000) | (2,639,000) | (1,445,000) | (150,000) | (1,159,000) | (1,345,000) |
| Pretax Income | 1,039,000 | 2,668,000 | 714,000 | 1,554,000 | 1,661,000 | (2,269,000) | 2,084,000 | 2,146,000 |
| Tax Provision | 342,000 | 853,000 | 526,000 | 613,000 | 372,000 | (2,246,000) | 520,000 | 773,000 |
| Net Income (Loss) | 695,000 | 1,816,000 | 186,000 | 938,000 | 1,286,000 | (22,000) | 1,561,000 | 1,370,000 |
| Earnings Per Share (Basic) | 0.39 | 1.02 | 0.10 | 0.52 | 0.72 | (0.02) | 0.88 | 0.77 |
| Earnings Per Share (Diluted) | 0.39 | 1.02 | 0.10 | 0.52 | 0.72 | (0.02) | 0.88 | 0.77 |
| Weighted Average Shares Outstanding (Basic) | 1,770,000 | 1,769,000 | 1,769,000 | 1,768,000 | 1,768,000 | 1,769,000 | 1,769,000 | 1,768,000 |
| Weighted Average Shares Outstanding (Diluted) | 1,774,000 | 1,773,000 | 1,772,000 | 1,771,000 | 1,772,000 | 1,773,000 | 1,772,000 | 1,771,000 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ABBV
AbbVie Inc. (NYSE: ABBV) is a stock listed on the New York Stock Exchange under the ticker symbol ABBV. It last traded at $294.89 (Oct 30, 2026, 4:00 PM ET), up 1.4% on the day. That gives AbbVie a market capitalisation of $513.9B and a price-to-earnings ratio of 81.4.
Over the past 52 weeks ABBV has traded between $190.75 and $292.67.
Revenue for the quarter ended Mar 31, 2026 was $15.0B; net income $695.0M. Revenue was up 12.4% from $13.3B in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $15.0B | $695.0M | 4.6% |
| Dec 31, 2025 | $16.6B | $1.8B | 10.9% |
| Sep 30, 2025 | $15.8B | $186.0M | 1.2% |
| Jun 30, 2025 | $15.4B | $938.0M | 6.1% |
From AbbVie’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…